BAFNA PHARMACEUTICALS
Back to Income Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹115 Cr | ₹85 Cr | ₹71 Cr | ₹42 Cr | ₹44 Cr |
What is the latest Revenue of BAFNA PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹115 Cr |
Mar2023 | ₹85 Cr |
Mar2022 | ₹71 Cr |
Mar2021 | ₹42 Cr |
Mar2020 | ₹44 Cr |
How is Revenue of BAFNA PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹115 Cr | 35.48 | |
Mar2023 | ₹85 Cr | 19.55 | |
Mar2022 | ₹71 Cr | 67.68 | |
Mar2021 | ₹42 Cr | -2.65 | |
Mar2020 | ₹44 Cr | - |
Compare Revenue of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹186.6 Cr | -1.6% | 9.5% | -21.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,155.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,295.0 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
CIPLA | ₹116,664.0 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,678.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,162.6 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | -1.6% |
9.5% |
-21.5% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses